Summary |
|
||||||||||
Variant origin |
|
||||||||||
Variant description |
|
||||||||||
Notes |
Trait Annotation
Mapping and Phenotype information for this QTL, its variants and associated markersJ:170533The mice used in this study were from the F16 generation of the LG/J X SM/J Advanced Intercross Line (Wustl:LG,SM-G16). The authors indicated 70 trait-specific QTL mapping to 64 locations, and of these 70 a total of 17 are significant at the genome-wide level. Fifty three are significant at the chromosome level. The 17 genome wide significant QTL are indicated with an '*' and can be viewed here on their respective chromosome mapping records (NCBI37/mm9). The authors mentioned that phenotypic variation in response to glucosestresswas indicated by using an intraperitoneal injection of 0.01 ml of 10% glucose solution per gram of body weight. The measurements taken over the course of 2 hours were used to calculate the area under the curve (AUC), which was used as overall measure of glucose tolerance.
Phenotypes were as follows: AUC_10wks indicates under the curve at 10 weeks AUC_20wks indicates area under the curve at 20 weeks bGLC_10wks indicates basal glucose level at 10 weeks bGLC_20wks indicates basal glucose level at 20 weeks, GLC indicates serum glucose level at necropsy INS indicates serum insulin level at necropsy Chr MGI Author Pheno LOD Peak Mb 5 prime 3 Prime 15 Ddiab52 Ddiab15a AUC_10wks 3.43 21.94 21.94 23.61 15 Ddiab53 Ddiab15b AUC_10wks 3.63 31.47 30.83 32.63 15 Ddiab54 Ddiab15c INS 3.47 34.26 31.47 35.03 15 *Ddiab55 Ddiab15d AUC_10wks 5.3 66.84 66 68.85 |
||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
![]() |
|